The FDA's recommendations serve to inform potential research sponsors on development protocols for psychedelics and to solicit comment from industry.
Briana Contreras
Advertisement
Articles by Briana Contreras
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Axsome Submits sNDA for AXS-05 to Treat Agitation in Alzheimer Disease
2
Dupilumab Meets All Endpoints in Phase 3 Study for Allergic Fungal Rhinosinusitis; FDA Grants Priority Review
3
5 Novel Mechanisms Reshaping Atopic Dermatitis Treatment and the Phase 2-3 Clinical Trials That Support Them
4
FMX 2025: 6 Takeaways for Primary Care Physicians
5
